This video consists of the following presentations:

Central role of diagnostics

Dr Kerrie Davies, Senior Scientific Advisor, Office of the Chief Scientific Officer, NHS England

Containment though education and stewardship

Dr Naomi Fleming, Regional Antimicrobial Stewardship Lead for the East of England, NHS England and Improvement

Measurement through surveillance

William Malcolm, Pharmaceutical Adviser & Clinical Lead for SONAAR programme, ARHAI Scotland

Q&A

This video consists of the following presentations:

Conflict, natural disaster and the impact on AMR - what exactly can be done?

Dr Aula Abbara, Consultant in Infection/ General Medicine, Imperial College NHS Healthcare

Management of paediatric CNS infections

Dr Stefania Vergnano, Consultant Paediatric Infectious Diseases & Immunology, Bristol Royal Hospital for Children

Hospital Acquired Pneumonia

Dr Dan Wootton, NIHR Advanced Fellow, Senior Clinical Lecturer and Honorary Consultant Respiratory Physician, University of Liverpool

Managing sore throats

Dr Efi Mantzourani, Reader, Cardiff School of Pharmacy

Q&A

This video consists of the following presentations:

The use of machine learning in accurate and rapid antibiotic susceptibility testing

Dr Katja Fromm, Resistell

AI: Improving decision-making in infection management

Dr Tim Rawson, Imperial College London

Q&A

AGM

This video consists of the following presentations:

Vanguard surveillance to inform the treatment of drug resistant infections

Professor Andrew Seaton, Consultant in Infectious Diseases and General Medicine, NHS Greater Glasgow and Clyde

This video consists of the following presentations:

UK delinkage scheme - where to next?

Professor Philip Howard OBE, AMR Regional Antimicrobial Stewardship Lead, NHS England & NHS Improvement - North-East & Yorkshire, UK

National and regional pull incentives

Deepali Patel, Director of International Policy, AMR Action Fund

Q&A

This video consists of the following presentations:

SESSION SEVEN - Garrod Lecture

This video consists of the following presentations:

The microbiome

Dr Chrysi Sergaki, Principal Scientist - Microbiome Group Leader, MHRA

Bacteriophages - an opportunity too good to miss?

Dr Ben Temperton, Associate Professor of Microbiology, University of Exeter

Q&A

This video consists of the following presentations:

Setting the Scene. Experience from Scotland

Professor Andrew Seaton, Consultant in Infectious Diseases and General Medicine, NHS Greater Glasgow and Clyde

Dr Kieran Hand, AMR National Clinical Lead for Pharmacy & Prescribing, NHS England

Pharmacy First service in England

Panel discussion Chaired by:

Dr Annie Joseph, Consultant Microbiologist, Nottingham University Hospitals NHS Trust

Q&A

This video consists of the following presentations:

Antimicrobial resistance and death certification: are we there yet?

Dr Ioannis Baltas, ST3 Infectious Diseases & Medical Microbiology NIHR Academic Clinical Fellow, University College London

Beyond Borders: A Global Risk Analysis of Extensively Drug-Resistant Typhoid Outbreaks in Pakistan

Dr Saeed Ahmad, Doctoral Researcher (Epidemiology & Public Health), Tampere University, Finland

Scale and Spread of a Quality Improvement Initiative Promoting Metronidazole Intravenous to Oral Switch (IVOST) in the Acute Hospital Setting: Antimicrobial Stewardship, Patient Safety, Workforce and Environmental Sustainability Benefits

Dr Rachael Rodger, Antimicrobial Pharmacist, NHS Greater Glasgow & Clyde

UKHSA Start Smart Then Focus Antimicrobial Stewardship: Effective Implementation During the COVID-19 Pandemic at an NHS Foundation Trust in the UK

Dr Rasha Abdelsalam Elshenawy, Department of Clinical, Pharmaceutical & Biological Sciences, University of Hertfordshire

Q&A

This video consists of the following presentations:

For

Dr Beatriz Larru Martinez, Consultant in Paediatric Infectious Diseases, Alder Hey Children's NHS Foundation Trust

Against

Dr Katja Doerholt, Paediatric Infectious Diseases Consultant, St. George's University Hospital London

Discussion

This video consists of the following presentations:

Scene setting

Dr Catrin Moore, Reader in Global Health & Infectious Diseases, St. George’s, University of London

For

Professor Will Gaze, University of Exeter Medical School

Against

Professor Alan McNally, Institute of Microbiology & Infection Professor in Microbial Evolutionary Genomics, University of Birmingham

Discussion

This video consists of the following presentations:

Welcome and opening remarks

Dr David Jenkins, University Hospitals of Leicester NHS Trust & BSAC President

Management of imported infections - CPE from Ukranian casualties treated in The Netherlands

Dr Daan Notermans, Medical Microbiologist, Dutch National Institute for Public Health and the Environment (RIVM)

Tuberculosis - programmatic testing and treatment for latent tuberculosis in migrants

Professor Ajit Lalvani, NIHR Health Protection Research Unit in Respiratory Infections, Imperial College London

Group A streptococcus pleural empyema in children

Dr Thomas Christie Williams, Wellcome Trust ECAT Clinical Lecturer, The University of Edinburgh & Registrar in Respiratory Paediatrics at the Royal Hospital for Children, Glasgow

This video consists of the following presentations:

Balancing the opportunity and risk: the political importance of making this happen

Professor Dame Sally Davies, UK Government Special Envoy on Antimicrobial Resistance, UK Department of Health and Social Care

Death certification and AMR

Dr Alan Fletcher, National Medical Examiner for England and Wales

What education, training and advocacy is now needed?

Dr David Jenkins, University Hospitals of Leicester NHS Trust & BSAC President

This video consists of the following presentations:

New models of antimicrobial funding in England

Professor Philip Howard OBE, AMR Regional Antimicrobial Stewardship Lead, NHS England & NHS Improvement - North-East & Yorkshire, UK and immediate Past President, BSAC

UKAR update

Professor Gareth Jones, Professor in Epidemiology at the University of Aberdeen and Co-Chief Investigator of the UK Antimicrobial Registry

This video consists of the following presentations:

Systemic fungal infections - the stewardship challenges

Ms Laura Whitney, Regional Antimicrobial Stewardship Lead London, NHS England and NHS Improvement

Implementation of an antifungal stewardship program and the impact on a stem cell transplant centre

Mr Richard Wilson, Research Pharmacist, Imperial College London

Candida resistance in the ICU

Dr Tihana Bicanic, Reader & Consultant in Infectious Diseases, St George’s University of London & St George’s Hospital

This video consists of the following presentations:

Rethinking AMS: New ideas for appropriate access from India

Dr Ramanan Laxminarayan, President of the One Health Trust, Senior Research Scholar, Princeton University

This video consists of the following presentations:

Understanding the role of accessory genes in AMR phenotype using interpretable machine learning models.

Miss Lucy Dillon, PhD Student, Queen's University Belfast

The consumption of human antibiotics in veterinary medicine, in Estonia, 2006–2022

Mrs Marju Sammul, PhD Student, Estonian University of Life Sciences

Patterns of general practitioner and nurse independent prescriber prescriptions for antibiotics dispensed in the community in England: A retrospective analysis

Professor Molly Courtenay, Cardiff University

Penicillin and cephalosporin cross-reactivity; a single centre UK study

Miss Eve Duke, Pharmacist, Leeds Teaching Hospitals Trust

This video consists of the following presentations:

How do we translate policy to practice in the UK

Dr Louise Savic, Leeds Teaching Hospitals

Penfast study - lessons from Australia

Associate Professor Jason Trubiano, Infectious Diseases Physician & NHMRC Early Career Researcher, University of Melbourne, Department of Medicine (Austin Health)

This video consists of the following presentations:

Nothing changes unless it changes: The role of rapid diagnostics in hepatology

Dr Vishal Patel, Consultant Hepatologist, Liver Unit, King's College Hospital London & Principal Investigator, The Roger Williams Institute of Hepatology, Foundation for Liver Research

This video consists of the following presentations:

The post treatment impact of antimicrobials in the environment – a threat to yet be understood?

Professor Will Gaze, University of Exeter

Achieving sustainable antimicrobial usage: exploring the “how” from a systems perspective

Dr Kelly Thornber, Research Fellow, University of Exeter

Confronting a Permacrisis - the intersection between antimicrobial resistance, climate change and biodiversity loss

Mr Tom Tayler, Aviva Investors

This video consists of the following presentations:

Phage therapy

Professor Martha Clokie, Professor of Microbiology, University of Leicester

Large scale cohort studies and genomics to understand Staphylococcus aureus colonisation and biology

Dr Ewan Harrison, Wellcome Sanger Institute

Faecal transplants

Professor Mark Wilcox, Leeds Teaching Hospitals NHS Trust

Do it simple, do it well: reducing infection through low cost preventative measures

Professor Tim Walsh, University of Oxford

This video consists of the following presentations:

The AMR Narrative

Ms Vanessa Carter, AMR Patient Survivor & One Health Advocate and Founder, The AMR Narrative

This video consists of the following presentations:

The vital role of data in pandemic preparedness and management

Dr Susan Hopkins, Consultant, PHE/ DHSC / Royal Free Hospital

Data-driven communication to raise awareness of AMR and drive rational use of antibiotics

Dr Alex Costa, Health Programme Team, UNICEF

Q&A

This video consists of the following presentations:

Was the Longitude Prize too early? Are we ready for rapid diagnostics?

Mr Daniel Berman, Director, Global Health, Nesta Challenges

The blood culture pathway - how can we get it right?

Dr Michael Weinbren, AMR Diagnostics Programme Clinical Lead, NHS England and NHS Improvement

The effectiveness of rapid diagnostic tests for antimicrobial resistance

Dr Rebecca Glover, Assistant Professor in Health Policy, LSHTM

Q&A

All speakers, plus panellist Dr Rosemary Stevenson, AMR Diagnostics Programme Lead (Science & Policy Lead), NHS England and NHS Improvement

This video consists of the following presentations:

Lessons learnt from COVID vaccine development 

Dr Charlie Weller, Head of Prevention, Infectious Diseases, Wellcome

Pneumococcal vaccine – a success story in progress

Professor Keith Klugman, Director, Bill & Melinda Gates Foundation

Q&A

This video consists of the following presentations:

The GRAM report - implications for infection management

Dr Christopher J.L. Murray, Chair of Health Metrics Sciences, University of Washington & Director of the Institute for Health Metrics and Evaluation (IHME).

This video consists of the following presentations:

Interactive panel presentations and discussion on the successes and failures of behavioural science interventions

Dr Esmita Charani, Senior Lead Pharmacist, Imperial College London, Professor Carolyn Tarrant, Professor of Health Services Research, University of Leicester, Dr Eva Krockow, Lecturer in Psychology, University of Leicester, Ms Sally Tipping, Specialist Antimicrobial Pharmacist, Royal Devon & Exeter Hospital

Panel discussion

This video consists of the following presentations:

Nuances of implementing antibiotic stewardship in high prescribing English general practices: an implementation study

Dr Sarah Tonkin-Crine, Associate Professor and Health Psychologist, University of Oxford

TRAIL, IP-10, CRP Host-protein Signature score distinguishes between Viral and Bacterial Infection in Sepsis Patients

Dr Jeroen Stas, Medical Affairs Manager, MeMed Diagnostics

ST97 Staphylococcus aureus and oxacillin resistance: An emerging challenge for microbiologists?

Gareth Hughes, ST7 Microbiology & Infectious diseases, UKHSA Lab

Q&A

This video consists of the following presentations:

Approaches to Complex Urinary Tract Infections

Dr Annie Joseph, Consultant Microbiologist, Nottingham University Hospitals NHS Trust, Dr Tom Lewis, Northern Devon NHS Healthcare Trust

Intra-abdominal infections

Professor Mark Wilcox, Consultant / Head of Microbiology Research & Development / and Infection Lead of the Leeds NIHR Diagnostic Technologies Medical Technology and In Vitro Diagnostic Co-operative, Leeds Teaching Hospitals NHS Trust

Management of penicillin allergy labels

Dr Jonathan Sandoe, Associate Professor, University of Leeds, Leeds Teaching Hospitals NHS Trust

Recent trends in serious fungal infection incidence, mortality and antifungal resistance

Professor David Denning, Professor of Infectious Diseases in Global Health, The University of Manchester

Q&A

This video consists of the following presentations:

Accelerating appropriate access to new antibiotics: Cefiderocol as a pathfinder

Jennifer Cohn, Global Access Project Leader, Global Antibiotic Research and Development Partnership (GARDP)

Laboratory capacity for all - developing mobile laboratory services

Dr Alessandra Natale, Research Coordinator, Médecins Sans Frontières

Q&A

This video consists of the following presentations:

Supporting shared learning and stakeholder collaboration via the Global Antimicrobial Stewardship hub (GASP-h)

Professor Dilip Nathwani

Developing a UK Antimicrobial Registry – a BSAC collaboration with academic and industry partners

Dr Jacqueline Sneddon, Programmes Manager, BSAC

Launch of the Global Antimicrobial Stewardship Accreditation Scheme (GAMSAS) – supporting a quality improvement approach

Dr David Jenkins, Consultant Medical Microbiologist, Infection Prevention doctor & BSAC President, University Hospitals of Leicester NHS Trust

Civil-private sector-public alliance: AMR, COVID-19, and the Investment Community

Professor Dilip Nathwani, Dr Claudie Charbonneau, Pfizer

Panel discussion & Q&A

This video consists of the following presentations:

Interpreting EUCAST recommendations

Pegah Hafezi, AST LEAD, Severn Pathology, Bristol

Implementing RAST in routine microbiology services

Dr Per Rydstrom, Consultant clinical microbiologist, Clinical microbiology for Kronoberg and Blekinge County, Sweden

Whole genome sequencing as a tool for prediction of antimicrobial resistance: pros & cons

Dr Massimo Mentasti, Senior Scientist, Public Health Wales NHS Trust

Q&A

Keynote presentation

Spotlight on AMR and Infection management - Global issues

Impact of AMR in challenging populations

Improving antimicrobial prescribing in children

The importance of time to appropriate antibiotic therapy

Resistance game changers and challenges

AMR and big data: the art of the possible

Drugs, devices and diagnostics - the new frontiers

Hot topics

Clinical quandaries - case based presentations on global challenges

Antimicrobial challenges

Panel discussion

Shortages, stockouts and scarcity: The issues facing the security of antibiotic supply and the role for pharmaceutical companies

Dr Deidre Cogan, Writer/Editor, Access to Medicine Foundation

The link between social and economic deprivation and AMR - via Skype

Professor Ramanan Laxminarayan, Director and Senior Fellow, The Center for Disease Dynamics, Economics & Policy, Washington DC

Innovation and AMR

Professor Dilip Nathwani OBE, Director, Academic Health Sciences Partnership [AHSP] in Tayside, Consultant Physician and Honorary Professor of Infection, Ninewells Hospital and Medical School, Dundee

Tailoring stewardship to context: Drivers and patterns of antibiotic prescribing and consumption in rural China

Professor Helen Lambert, Professor of Medical Anthropology, Bristol Medical School, University of Bristol

UK Initiatives to Reduce Inappropriate Antibiotic Prescribing

Professor Alan Johnson, Head of Surveillance in the Healthcare-Associated Infection & Antimicrobial Resistance (HCAI & AMR) Division of the National Infection Service, Public Health England

Bacteriophages - how significant will their impact be?

Professor Martha Clokie, Professor of Microbiology, University of Leicester

It all gone to worms - the role of odilorhabdins!

Dr Philippe Villain-Guillot, CEO, Nosopharm

Role of digital PCR in high accuracy measurement in infectious diseases

Dr Denise O’Sullivan, Science Leader, LGC

Inter-laboratory study comparing bacterial AMR predictions from WGS data

Dr Ronan Doyle, Research Associate, Great Ormond Street Hospital NHS Foundation Trust

Developing metrology to support antimicrobial discovery, validation and screening

Professor Max Ryadnov, Biometrology Leader, National Physical Laboratory

Standardisation of procalcitonin measurement

Dr Amandine Boeuf, Researcher, Laboratoire de Métrologie et d’Essai (LNE)

Life after a MDR GNB Outbreak - Treatment pathway change in Manchester and emerging data

Dr Louise Sweeney, Central Manchester University Hospitals NHS Trust

Garrod Lecture 2019: MDR efflux in Gram negative bacteria - how understanding resistance led to a new tool for drug discovery

Professor Laura Piddock, University of Birmingham and GARDP

Global Knowledge exchange - Antimicrobial Resistance and Stewardship

Professor Dilip Nathwani OBE, Director, Academic Health Sciences Partnership [AHSP] in Tayside, Consultant Physician and Honorary Professor of Infection, Ninewells Hospital and Medical School, Dundee

Stewardship

Professor Dilip Nathwani OBE, Director, Academic Health Sciences Partnership [AHSP] in Tayside, Consultant Physician and Honorary Professor of Infection, Ninewells Hospital and Medical School, Dundee

Diagnostics

Dr Till Bachmann, Reader in Personalised Medicine in Infectious Diseases, Deputy Head of Division of Infection and Pathway Medicine, University of Edinburgh

Behaviour Change & AMR

Dr Esmita Charani, Senior Lead Pharmacist, Imperial College London

Managing self-limiting infections in community pharmacies: a cluster randomised controlled trial

Ms Eno Umoh, Public Health England

Ceftazidime/avibactam in paediatrics: Challenges and treatment outcomes

Mrs Frances Garraghan, Lead antimicrobial pharmacist, Manchester University Foundation Trust

Educating the workforce in AMR – too many gimmicks or coming up trumps?

Dr Angharad Davies, Clinical Associate Professor, Swansea University Medical School

Why do dentists prescribe antibiotics for adults with toothache or infection?

Mrs Wendy Thompson, University of Leeds

Structuring the Management of High-Risk Skin Infections: A Model Care Pathway

Dr Abid Hussain, University Hospitals of Birmingham NHS Foundation Trust

Current and future directions for rapid AMR diagnostics

Dr Till Bachmann, Reader in Personalised Medicine in Infectious Diseases, Deputy Head of Division of Infection and Pathway Medicine, University of Edinburgh

MALDI-TOF-MS - beyond species ID

Dr Belén Rodriguez Sanchez, Hospital Gregorio Maranon, Madrid

AMR detection in the WGS era

Professor John Rossen, Medical Molecular Microbiologist, University of Groningen, The Netherlands

Antimicrobial resistance: how journalism can help

Ms Madlen Davies, Health and science editor, The Bureau of Investigative Journalism

Public perception of antimicrobials and AMR – how it is shaped and informed

Dr Laurie Denyer Willis, Research Fellow, London School of Hygiene and Tropical Medicine

Public health driven R&D of antibiotics for priority drug resistant infections

Dr Seamus O'Brien, R&D Director, Global Antibiotic R&D Partnership (GARDP)

CARB-X: Building A Portfolio of New Antibiotics, Vaccines & Diagnostics with Open Science

Dr Richard Lawson, Director of the CARB-X Program Management Office

Swab and send – discovering new antimicrobials from natural products

Dr Adam Roberts, Senior lecturer, Liverpool School of tropical Medicine

What's new in conjugate vaccine development against infectious disease

Dr Viliam Pavliak, Senior Advisor, International Vaccine Institute

The global roadmap for STI vaccine development - state of the art review

Dr David McIntosh, Honorary Clinical Senior Lecturer, Imperial College London

The of Role of Vaccines in Preventing AMR

Dr Rajeka Lazarus, Consultant in Microbiology and Infectious Diseases, Bristol

Conservation of antibiotics is the ONLY way forward

Heterogencity: A little bit of everything will work wonders - cycling antibiotics is the future!

Welcome and Opening Remarks

Professor Dilip Nathwani OBE

Global epidemiology of infectious diseases and AMR and the role of informatics

Professor Michael Osterholm

Global burden of bacterial infections: the role of vaccines in reducing AMR

Dr David McIntosh

Enabling the adoption of new diagnostics within the UK healthcare system

Dr Fiona Carragher

Stewardship in Kerala, India

Dr Sanjeev Singh

Experiences from Latin America

Dr Gabriel Levy Hara

Stewardship in Africa - challenges and opportunities

Dr Brian Godman

Diagnostic testing for point of care C Reactive Protein and how it can guide antibiotic prescribing

Supported by Abbott

Technology overview - The Accelerate Pheno™ System

Steve Holland

Clinical Experiences of the Accelerate Pheno™ System at an NHS District General Hospital

Dr Claire Thomas

What surveillance do we have for AMR?

Dr Berit Muller-Peabody

Why is surveillance important after introducing vaccines?

Dr Michael Edelstein

Rapid surveillance in emergency situations: The Zika Experience

Professor Jimmy Whitworth

Legacy planning – what did we learn from Ebola

Dr Timothy Brooks

Procalcitonin – lessons and limitations

Dr Stephan Harbarth

MALDI-TOF and its impact on patient care

Dr Savita Gossain

Syndromic approaches to infection detection - TaqMan array cards

Dr Martin Curran

Alternative models of care: Nurses in antimicrobial stewardship

Jo McEwen

Successful stewardship in hospital settings (HDU and general)

Dr Charles Luyt

Antimicrobial stewardship in long term care facilities (LTCFs)

Dr Elizabeth Beech

Global Antimicrobial Resistance Surveillance System (GLASS)

Professor Roman Kozlov

Global PPS

Professor Herman Goossens

New Vaccines against Epidemic Infectious Diseases

Dr David McIntosh

New for old and emerging treatments - a summary of new agents in development

Professor Alasdair MacGowan

Clinical need for rapid diagnostic tests

Professor Herman Goossens

Skin patch antibiotics - the next big thing?

Professor Ryan Donnelly

Harnessing the host-protein response to distinguish between bacterial and viral infections

Dr Liran Shani

Lefamulin: the potential for one antibiotic rather than two in CABP

Professor Mark Wilcox

Rapid susceptibility testing: new phenotypic and non-WGS genotypic approaches

Dr Oskar Ekelund

WGS-based susceptibility testing for TB: from research to service delivery

Professor Grace Smith

Should WGS be used for susceptibility testing of bacteria other than TB?

Dr Matthew Ellington

Preparing for the Black Swans of resistance

Professor David Livermore

Progressing the new essential medicines agenda

Professor Celine Pulcini

Use of reporting guidelines to design, report and referee antibiotic stewardship studies

Dr Sheldon Stone

Latest clinical data and early experience of managing difficult-to-treat Gram-negative infections with a novel β-lactamase inhibitor combination

Supported by Pfizer

Current thinking about cephalosporins and CDI & AMR. Can a new cephalosporin help?

Supported by Cardiome

Delivering open access, high impact-low cost education to all

Professor Dilip Nathwani OBE

Developing a global community of practice

Dr Elizabeth Tayler

Welcome

Professor Dilip Nathwani OBE, President, BSAC

The current global and UK epidemiology of GNB infections

Professor Timothy Walsh, Professor of Medical Microbiology and Antibiotic Resistance, Cardiff University

Burden and current global management on GNB infections: Lessons from a global PPS

Dr Ann Versporten, Global PPS Coordination Centre, University of Antwerp, Antwerp

Clinical presentations and impact of GNB infections in the UK

Dr Gavin Barlow, Infectious Diseases Consultant, Hull & East Yorkshire Hospitals NHS Trust

Hospital antibiotic prescribing to minimise AMR - the Antibiotic Reduction Kit (ARK-Hospital) Programme

Professor Martin Llewelyn, Reader in Infectious Diseases, Brighton and Sussex Medical School

NDM, ESBL and KPC - the US experience

Dr Lilian Abbo, Chief Infection Prevention & Antimicrobial Stewardship JHS President WIAM Advisory Board UMMSM, Jackson Health System, University of Miami, United States

UK Guidelines for GNB infections

Professor Peter Hawkey, PHE Lead Public Health Microbiologist, Heart of England NHS Foundation Trust, Birmingham UK

Optimising PK/PD for treatment of GNB

Dr Federico Pea, Institute of Clinical Pharmacology, University Teaching Hospital of Udine, Italy

A randomised controlled trial evaluating the TARGET (Treat Antibiotics Responsibly, Guidance, Education, Tools) Antibiotics toolkit

Miss Leah Jones, Trainee Health Psychologist & Research Assistant, Public Health England

Rapid phenotypic susceptibility testing of bacteria: SLIC by name and slick by nature

Dr Robert Hammond, Post Doctoral Research Fellow, University of St Andrews

Quality indicators and quantity metrics for responsible antibiotic use, lessons from DRIVE-AB

Dr Vera Vlahović-Palčevski, Clinical Pharmacologist, DRIVE-AB & University of Rijeka, Croatia

UK approach to use of metrics and targets for GNB infections

Dr Susan Hopkins, Consultant in Infectious Diseases & Microbiology, Royal Free Hospital, NHS Trust, London

GNB infections and stewardship

Professor Dilip Nathwani OBE, Consultant Physician and Honorary Professor of Infection, University of Dundee, Dundee UK

Prevention of GNB infections

Professor Peter Wilson, Consultant Microbiologist, UCHL Foundation NHS Trust, London

Drug discovery to combat GNB infections: current challenges and possible progress

Professor Mike Ferguson, Regius Professor and Associate Dean for Research Strategy, Biologicial Chemistry and Drug Discovery, University of Dundee, Dundee UK

BSAC AGM

Professor Dilip Nathwani OBE, President, BSAC

BSAC Virtual Learning Environment

Professor Dilip Nathwani OBE, President, BSAC & Mr Mark Lester, FutureLearn